PRN: Global Organ Transplant Immunosuppressant Market to Grow at a CAGR of 3.8% by 2021 - Key Vendors are Novartis, Astellas Pharma, Pfizer & Sanofi

18/lug/2017 14:20:48 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Organ Transplant Immunosuppressant Market to Grow at a CAGR of 3.8% by 2021 - Key Vendors are Novartis, Astellas Pharma, Pfizer & Sanofi


DUBLIN, July 18, 2017 /PRNewswire/ --

The "Global Organ Transplant Immunosuppressant Market 2017-2021" report has been added to Research and Markets' offering.


The global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.

The report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is growing trend of medical tourism. Medical tourism is the act of traveling abroad to receive medical, dental, and cosmetic care. Medical tourism for getting an organ transplant is also called as transplant tourism, and the significantly lower cost for availing the best practice care is generally the primary motivation. In addition, the insufficient organ supply is another reason for the emergence of medical/transplant tourism. However, to bridge the gap between demand and supply, the introduction of the artificial organ has served the purpose. However, the high cost associated with artificial organ transplant, especially in the US has further compelled the individuals to visit the less developed countries to get an organ transplant at competitive prices.

According to the report, one of the major drivers for this market is increased incidence of organ failure. Globally, there is a high demand for tissues and organs such as bone marrow, heart, liver, kidney, and lungs. The increased alcohol consumption, unhealthy lifestyles and food habits, and drug intake are the leading causes of organ failure. In addition, the rise in aging population results in increased demand for organs for transplantation.

Further, the report states that one of the major factors hindering the growth of this market is Insufficient organ supply. The global organ transplant immunosuppressant market is witnessing a high demand for donor organ due to increasing incidences of organ failure. Despite advances in the medicine and technology, and increased awareness of organ donation and transplantation, the increasing gap between supply and demand continues to pose a major challenge for the market growth.

Key vendors

  • Novartis,
  • Astellas Pharma,
  • Pfizer,
  • Sanofi,

Other prominent vendors

  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Introduction to organ transplantation

PART 06: Market landscape

PART 07: Key clinical trials

PART 08: Market segmentation by drug class

PART 09: Market segmentation by therapeutic application

PART 10: Geographical segmentation

PART 11: Decision framework

PART 12: Drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Key vendor analysis

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl